All > Hawaii

LINCC intervention - enable co-schedule feature for Family Planning

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Family Planning+2 MoreLINCC intervention - enable co-schedule feature - Behavioral
Eligibility
18 - 45
Female
What conditions do you have?
Select

Study Summary

This trial will improve access to timely contraception for women who deliver babies, by developing and implementing a new approach to connect contraception care with newborn care.

Eligible Conditions
  • Family Planning
  • Birth Control
  • Postpartum

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
ENABLE-COPD
2
ENABLE Cornerstone
2
IV Oxytocin

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 24 months

2 months
Number of patients who receive contraception by two months postpartum
24 months
Number of patients who present with a short inter-pregnancy interval pregnancies
6 months
Number of patients who receive contraception by six months postpartum

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
ENABLE-COPD
3
ENABLE Cornerstone
3
IV Oxytocin

Trial Design

2 Treatment Groups

Control - Aim 2
1 of 2
Intervention - Aim 2
1 of 2

Active Control

Experimental Treatment

1198 Total Participants · 2 Treatment Groups

Primary Treatment: LINCC intervention - enable co-schedule feature · No Placebo Group · N/A

Intervention - Aim 2
Behavioral
Experimental Group · 1 Intervention: LINCC intervention - enable co-schedule feature · Intervention Types: Behavioral
Control - Aim 2NoIntervention Group · 1 Intervention: Control - Aim 2 · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 months

Who is running the clinical trial?

University of Illinois at ChicagoOTHER
540 Previous Clinical Trials
1,550,279 Total Patients Enrolled
AllianceChicagoOTHER
4 Previous Clinical Trials
6,652 Total Patients Enrolled
Rush University Medical CenterLead Sponsor
390 Previous Clinical Trials
152,336 Total Patients Enrolled
Sadia Haider, MDPrincipal InvestigatorRush University Medical Center
Rachel Caskey, MDPrincipal InvestigatorUniversity of Illinois at Chicago

Eligibility Criteria

Age 18 - 45 · Female Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Illinois100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Heartland Health Centers100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top